Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Pharmaceutical Design, Volume 19 - Number 14






Riboflavin Analogs as Antiinfectives: Occurrence, Mode of Action, Metabolism and Resistance

, 19(14): 2552 - 2560

Danielle Biscaro Pedrolli, Frank Jankowitsch, Julia Schwarz, Simone Langer, Shinobu Nakanishi, Eva Frei and Matthias Mack


DOI: 10.2174/1381612811319140006




Redox Proteins as Targets for Drugs Development Against Pathogens

, 19(14): 2594 - 2605

Daniela L. Catalano-Dupuy, Arleth Lopez-Rivero, Anabel Soldano and Eduardo A. Ceccarelli


DOI: 10.2174/1381612811319140009






Biosynthesis of Flavin Cofactors in Man: Implications in Health and Disease

, 19(14): 2649 - 2675

Maria Barile, Teresa Anna Giancaspero, Carmen Brizio, Concetta Panebianco, Cesare Indiveri, Michele Galluccio, Lodovica Vergani, Ivano Eberini and Elisabetta Gianazza


DOI: 10.2174/1381612811319140014



Editor-in-Chief

William A. Banks
(45093 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
(USA)

Biography View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Journal History

Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32

Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog